QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Supplemental Research Data All Versions of this Article: gad.1476206v1 20/20/2848    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wong, J. M.Y. Articles by Collins, K. Search for Related Content PubMed PubMed Citation Articles by Wong, J. M.Y. Articles by Collins, K. Social Bookmarking                   What's this?

Telomerase RNA level limits telomere maintenance in X-linked dyskeratosis congenita

Department of Molecular and Cell Biology, University of California at Berkeley, Berkeley, California 94720, USA

Dyskeratosis congenita (DC) patients suffer a progressive and ultimately fatal loss of hematopoietic renewal correlating with critically short telomeres. The predominant X-linked form of DC results from substitutions in dyskerin, a protein required both for ribosomal RNA (rRNA) pseudouridine modification and for cellular accumulation of telomerase RNA (TER). Accordingly, alternative models have posited that the exhaustion of cellular renewal in X-linked DC arises as a primary consequence of ribosome deficiency or telomerase deficiency. Here we test, for the first time, whether X-linked DC patient cells are compromised for telomerase function at telomeres. We show that telomerase activation in family-matched control cells allows telomere elongation and telomere length maintenance, while telomerase activation in X-linked DC patient cells fails to prevent telomere erosion with proliferation. Furthermore, we demonstrate by phenotypic rescue that telomere defects in X-linked DC patient cells arise solely from reduced accumulation of TER. We also show that X-linked DC patient cells averted from premature senescence support normal levels of rRNA pseudouridine modification and normal kinetics of rRNA precursor processing, in contrast with phenotypes reported for a proposed mouse model of the human disease. These findings support the significance of telomerase deficiency in the pathology of X-linked DC.

[Keywords: [Telomerase RNA; telomere length; dyskeratosis congenita; dyskerin; ribosomal RNA; pseudouridine]]

Received July 31, 2006; revised version accepted August 28, 2006.

² Corresponding author.

E-MAIL kcollins{at}berkeley.edu; FAX (510) 643-6334.

Supplemental material is available at http://www.genesdev.org.

Article published online ahead of print. Article and publication date are at http://www.genesdev.org/cgi/doi/10.1101/gad.1476206.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				L. Montanaro, D. Trere, and M. Derenzini Nucleolus, Ribosomes, and Cancer Am. J. Pathol., August 1, 2008; 173(2): 301 - 310. [Abstract] [Full Text] [PDF]

				B.-W. Gu, M. Bessler, and P. J. Mason A pathogenic dyskerin mutation impairs proliferation and activates a DNA damage response independent of telomere length in mice PNAS, July 22, 2008; 105(29): 10173 - 10178. [Abstract] [Full Text] [PDF]

				Y.-J. Chen, H. G. Campbell, A. K. Wiles, M. R. Eccles, R. R. Reddel, A. W. Braithwaite, and J. A. Royds PAX8 Regulates Telomerase Reverse Transcriptase and Telomerase RNA Component in Glioma Cancer Res., July 15, 2008; 68(14): 5724 - 5732. [Abstract] [Full Text] [PDF]

				D. Hockemeyer, W. Palm, R. C. Wang, S. S. Couto, and T. de Lange Engineered telomere degradation models dyskeratosis congenita Genes & Dev., July 1, 2008; 22(13): 1773 - 1785. [Abstract] [Full Text] [PDF]

				T. Vulliamy, R. Beswick, M. Kirwan, A. Marrone, M. Digweed, A. Walne, and I. Dokal From the Cover: Mutations in the telomerase component NHP2 cause the premature ageing syndrome dyskeratosis congenita PNAS, June 10, 2008; 105(23): 8073 - 8078. [Abstract] [Full Text] [PDF]

				Y. Cao, L. I. Huschtscha, A. S. Nouwens, H. A. Pickett, A. A. Neumann, A. C-M. Chang, C. D. Toouli, T. M. Bryan, and R. R. Reddel Amplification of Telomerase Reverse Transcriptase Gene in Human Mammary Epithelial Cells with Limiting Telomerase RNA Expression Levels Cancer Res., May 1, 2008; 68(9): 3115 - 3123. [Abstract] [Full Text] [PDF]

				F. D. Goldman, G. Aubert, A. J. Klingelhutz, M. Hills, S. R. Cooper, W. S. Hamilton, A. J. Schlueter, K. Lambie, C. J. Eaves, and P. M. Lansdorp Characterization of primitive hematopoietic cells from patients with dyskeratosis congenita Blood, May 1, 2008; 111(9): 4523 - 4531. [Abstract] [Full Text] [PDF]

				G. Aubert and P. M. Lansdorp Telomeres and Aging Physiol Rev, April 1, 2008; 88(2): 557 - 579. [Abstract] [Full Text] [PDF]

				A. Marrone, A. Walne, H. Tamary, Y. Masunari, M. Kirwan, R. Beswick, T. Vulliamy, and I. Dokal Telomerase reverse-transcriptase homozygous mutations in autosomal recessive dyskeratosis congenita and Hoyeraal-Hreidarsson syndrome Blood, December 15, 2007; 110(13): 4198 - 4205. [Abstract] [Full Text] [PDF]

				C. K. Garcia, W. E. Wright, and J. W. Shay Human diseases of telomerase dysfunction: insights into tissue aging Nucleic Acids Res., December 3, 2007; 35(22): 7406 - 7416. [Abstract] [Full Text] [PDF]

				M. Bessler, H.-Y. Du, B. Gu, and P. J. Mason Dysfunctional telomeres and dyskeratosis congenita Haematologica, August 1, 2007; 92(8): 1009 - 1012. [Full Text] [PDF]

				J. J. Fuster and V. Andres Telomere Biology and Cardiovascular Disease Circ. Res., November 24, 2006; 99(11): 1167 - 1180. [Abstract] [Full Text] [PDF]